Development of immortalized hepatocyte-like cells from hMSCs

Methods in Molecular Biology

Volumn 826, Issue , 2012, Pages 73-87

  Wongkajornsilp, Adisak ^a   Sa Ngiamsuntorn, Khanit ^a   Hongeng, Suradej ^b  

^a MAHIDOL UNIVERSITY   (Thailand)

^b MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Cell immortalization; CYP450; Drug metabolism; Hepatocyte differentiation; Hepatocyte like cell; hMSC; Toxicology

Indexed keywords

BMI1 PROTEIN, HUMAN; CYTOCHROME P450; ISOENZYME; NUCLEAR PROTEIN; ONCOPROTEIN; REPRESSOR PROTEIN; TELOMERASE; TERT PROTEIN, HUMAN;

ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SEPARATION; CELL SHAPE; CULTURE TECHNIQUE; CYTOLOGY; ENZYME INDUCTION; FLUORESCENT ANTIBODY TECHNIQUE; GENETIC TRANSDUCTION; GENETICS; HUMAN; LIVER CELL; MESENCHYMAL STEM CELL; METABOLISM; METHODOLOGY; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION;

CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SEPARATION; CELL SHAPE; CYTOCHROME P-450 ENZYME SYSTEM; ENZYME INDUCTION; FLUORESCENT ANTIBODY TECHNIQUE; HEPATOCYTES; HUMANS; ISOENZYMES; MESENCHYMAL STEM CELLS; NUCLEAR PROTEINS; PROTO-ONCOGENE PROTEINS; REAL-TIME POLYMERASE CHAIN REACTION; REPRESSOR PROTEINS; TELOMERASE; TRANSDUCTION, GENETIC;

EID: 84855910106     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-61779-468-1_7     Document Type: Article

References (19)

1. Gomez-Lechon MJ, Donato MT, Castell JV, Jover R. Human hepatocytes in primary culture: the choice to investigate drug metabolism in man. Curr Drug Metab. 2004 Oct;5(5):443-62. (Pubitemid 39276606)
2. Rodriguez-Antona C, Donato MT, Boobis A, Edwards RJ, Watts PS, Castell JV, et al. Cytochrome P450 expression in human hepatocytes and hepatoma cell lines: molecular mechanisms that determine lower expression in cultured cells. Xenobiotica. 2002 Jun;32(6):505-20. (Pubitemid 34743622)
3. Gomez-Lechon MJ, Castell JV, Donato MT. Hepatocytes-the choice to investigate drug metabolism and toxicity in man: in vitro variability as a refl ection of in vivo. Chem Biol Interact. 2007 May 20;168(1):30-50. (Pubitemid 46659918)
4. Guguen-Guillouzo C, Corlu A, Guillouzo A. Stem cell-derived hepatocytes and their use in toxicology. Toxicology. 2010 Mar 30; 270(1):3-9.
5. Khetani SR, Bhatia SN. Microscale culture of human liver cells for drug development. Nat Biotechnol. 2008 Jan;26(1):120-6.
6. Youdim KA, Tyman CA, Jones BC, Hyland R. Induction of cytochrome P450: assessment in an immortalized human hepatocyte cell line (Fa2N4) using a novel higher throughput cocktail assay. Drug Metab Dispos. 2007 Feb;35(2):275-82. (Pubitemid 46148741)
7. Sinz M, Wallace G, Sahi J. Current industrial practices in assessing CYP450 enzyme induction: preclinical and clinical. AAPS J. 2008 Jun;10(2):391-400.
8. Banas A, Yamamoto Y, Teratani T, Ochiya T. Stem cell plasticity: learning from hepatogenic differentiation strategies. Dev Dyn. 2007 Dec;236(12):3228-41. (Pubitemid 350276382)
9. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, et al. Multilineage potential of adult human mesenchymal stem cells. Science. 1999 Apr 2;284(5411):143-7. (Pubitemid 29282067)
10. Jaiswal RK, Jaiswal N, Bruder SP, Mbalaviele G, Marshak DR, Pittenger MF. Adult human mesenchymal stem cell differentiation to the osteogenic or adipogenic lineage is regulated by mitogen-activated protein kinase. J Biol Chem. 2000 Mar 31;275(13):9645-52. (Pubitemid 30185197)
11. Nagai A, Kim WK, Lee HJ, Jeong HS, Kim KS, Hong SH, et al. Multilineage potential of stable human mesenchymal stem cell line derived from fetal marrow. PLoS One. 2007;2(12):e1272.
12. Ong SY, Dai H, Leong KW. Hepatic differentiation potential of commercially available human mesenchymal stem cells. Tissue Eng. 2006 Dec;12(12):3477-85. (Pubitemid 46037170)
13. Banas A, Teratani T, Yamamoto Y, Tokuhara M, Takeshita F, Quinn G, et al. Adipose tissue-derived mesenchymal stem cells as a source of human hepatocytes. Hepatology. 2007 Jul;46(1):219-28. (Pubitemid 47171939)
14. Zemel R, Bachmetov L, Ad-El D, Abraham A, Tur-Kaspa R. Expression of liver-specifi c markers in naive adipose-derived mesenchymal stem cells. Liver Int. 2009 Oct;29(9):1326-37.
15. Yamamoto Y, Banas A, Murata S, Ishikawa M, Lim CR, Teratani T, et al. A comparative analysis of the transcriptome and signal pathways in hepatic differentiation of human adipose mesenchymal stem cells. FEBS J. 2008 Mar;275(6):1260-73. (Pubitemid 351342220)
16. Kulkarni JS, Khanna A. Functional hepatocytelike cells derived from mouse embryonic stem cells: a novel in vitro hepatotoxicity model for drug screening. Toxicol In Vitro. 2006 Sep;20(6):1014-22. (Pubitemid 43959843)
17. Ek M, Soderdahl T, Kuppers-Munther B, Edsbagge J, Andersson TB, Bjorquist P, et al. Expression of drug metabolizing enzymes in hepatocyte-like cells derived from human embryonic stem cells. Biochem Pharmacol. 2007 Aug 1;74(3):496-503. (Pubitemid 46970845)
18. Unger C, Gao S, Cohen M, Jaconi M, Bergstrom R, Holm F, et al. Immortalized human skin fibroblast feeder cells support growth and maintenance of both human embryonic and induced pluripotent stem cells. Hum Reprod. 2009 Oct;24(10): 2567-81.
19. Kutner RH, Zhang XY, Reiser J. Production, concentration and titration of pseudotyped HIV-1-based lentiviral vectors. Nat Protoc. 2009;4(4):495-505.